Updates on the Role of Adrenal Steroidogenesis Inhibitors in Cushing’s Syndrome: A Focus on Novel Therapies

Pituitary - Netherlands
doi 10.1007/s11102-016-0742-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Review: Updates on Novel Therapies for Metastatic Renal Cell Carcinoma

Therapeutic Advances in Medical Oncology
Oncology
2010English

The Diversity of Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Allows Novel Pharmacological Therapies

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2000English

New Targeted Therapies in Myelodysplastic Syndrome: The Role of Farnesyltransferase and Proteasome Inhibitors

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2010English

Studies on the Metabolism of Trilostane,an Inhibitor of Adrenal Steroidogenesis.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1981English

Effect of Nitric Oxide on Rat Adrenal Zona Fasciculata Steroidogenesis

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
1998English

Adrenal Suppression and Cushing’s Syndrome Secondary to Ritonavir and Budesonide

South African Medical Journal
Medicine
2010English

A Case Report and Review on Cushing’s Syndrome

Indian Journal of Pharmacy Practice
2019English

Updates on Advanced Therapies for Acute Pulmonary Embolism

International Journal of Cardiovascular Practice
2016English

Iatrogenic Cushing’s Syndrome With Subsequent Adrenal Insufficiency in a Patient With Psoriasis Vulgaris Using Topical Steroids

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy